USD 1.41 billion
Report ID:
SQMIG35G2217 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
89
|Figures:
76
Global Deep Brain Stimulation Devices Market size was valued at USD 1.41 billion in 2022 and is poised to grow from USD 1.54 billion in 2023 to USD 3.14 billion by 2031, at a CAGR of 9.29% during the forecast period (2024-2031).
The global deep brain stimulation devices market is witnessing substantial growth, driven by several key factors. The increasing prevalence of neurological disorders, such as Parkinson's disease, essential tremor, and dystonia, is contributing to the rising demand for deep brain stimulation devices. Neurological disorders have become a significant burden on healthcare systems worldwide, necessitating effective treatment options like deep brain stimulation.
Technological advancements in deep brain stimulation devices have led to improved patient outcomes and expanded applications. Innovations such as rechargeable devices with longer battery life, improved targeting systems, and enhanced stimulation parameters have enhanced the efficacy and safety of deep brain stimulation procedures.
The growing acceptance of deep brain stimulation as an effective treatment modality, coupled with increasing awareness among patients and healthcare professionals, is propelling market growth. Deep brain stimulation offers significant benefits, including symptom relief, improved quality of life, and reduced medication dependence, which are driving its adoption.
Additionally, favorable reimbursement policies in developed regions are further facilitating market expansion. The rising healthcare expenditure and improving healthcare infrastructure in emerging economies are creating lucrative opportunities for deep brain stimulation device manufacturers to expand their presence in these regions.
Overall, the global deep brain stimulation devices market is poised for remarkable growth, fueled by the convergence of technological advancements, increasing prevalence of neurological disorders, and growing acceptance of deep brain stimulation as a viable treatment option.
US Deep Brain Stimulation Devices Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 1.41 billion
Largest Segment
Parkinson's disease
Fastest Growth
Parkinson's disease
Growth Rate
9.29% CAGR
To get more reports on the above market click here to Buy The Report
The global deep brain stimulation devices market can be segmented based on product type, application, end-user and region. Based on product type, the market can be segmented into rechargeable DBS devices and non-rechargeable DBS devices. Based on application, the market can be segmented into parkinson's disease, essential tremor, dystonia. Based on end-user, the market can be segmented into hospitals, ambulatory surgical centers, and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis By Product
The largest market segment in the deep brain stimulation devices market is the non-rechargeable DBS devices segment. Non-rechargeable devices have been widely adopted due to their cost-effectiveness and reliability. Non-rechargeable devices are known for their reliability and ease of use. Once implanted, they typically require minimal maintenance and have a predictable battery life. The simplicity of these devices makes them attractive to both patients and healthcare professionals, as they offer a straightforward and reliable solution for deep brain stimulation therapy.
The fastest growing segment in the deep brain stimulation devices market is the rechargeable DBS devices segment. These devices offer longer battery life, reducing the frequency of replacements and subsequent surgeries for battery replacement. Additionally, rechargeable DBS devices provide greater flexibility in adjusting stimulation parameters, allowing for personalized therapy and better patient outcomes. The growing demand for improved patient comfort and convenience, along with the advancements in rechargeable technology, has propelled the rapid growth of this segment in the market.
Analysis By Application
The largest market segment in the deep brain stimulation devices market is the Parkinson's disease segment. Parkinson's disease is a neurodegenerative disorder characterized by motor symptoms such as tremors, stiffness, and impaired movement. It is one of the most common neurological disorders, affecting a significant number of individuals worldwide. Deep brain stimulation has emerged as a highly effective treatment option for managing the symptoms of Parkinson's disease, leading to its widespread adoption and making it the largest market segment.
On the other hand, the fastest growing segment in the deep brain stimulation devices market is the essential tremor segment. Essential tremor is a neurological disorder characterized by involuntary and rhythmic shaking of the hands, head, or other parts of the body. While essential tremor is often considered a benign condition, it can significantly impact a person's quality of life and daily activities. Deep brain stimulation has shown promising results in reducing essential tremor symptoms and improving patients' functional abilities. The growing recognition of deep brain stimulation as an effective treatment option for essential tremor, coupled with increasing awareness and diagnosis rates, has contributed to the rapid growth of this segment in the market.
To get detailed analysis on other segments, Request For Free Sample Report
The largest market region is North America. North America holds a significant share in the market due to several key factors. The region has a well-established healthcare infrastructure with advanced medical facilities and expertise in neurology. This infrastructure enables efficient diagnosis and treatment of neurological disorders, leading to a higher demand for deep brain stimulation devices. North America has a high prevalence of neurological disorders, particularly Parkinson's disease, which drives the need for effective treatment options such as deep brain stimulation. Additionally, favorable reimbursement policies and strong healthcare expenditure further support the growth of the deep brain stimulation devices market in the region.
On the other hand, the fastest growing region is the Asia Pacific. The region is witnessing rapid growth due to several key factors. Firstly, the increasing healthcare expenditure and improving healthcare infrastructure in countries like China, India, and Japan have created a favorable environment for market growth. Rising disposable incomes, improving healthcare access, and a growing population contribute to the increased demand for deep brain stimulation devices in the region. Secondly, there is a rising prevalence of neurological disorders in Asia Pacific, primarily driven by changing lifestyles, aging populations, and environmental factors. This increasing disease burden fuels the adoption of deep brain stimulation devices as an effective treatment option.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Technological Advancements in Deep Brain Stimulation Devices
Restraints
High Cost of Deep Brain Stimulation Devices and Surgical Procedures
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the deep brain stimulation devices market is characterized by the presence of several key players striving to gain a significant market share. These players are focused on strategies such as product development, collaborations, mergers and acquisitions, and geographic expansions to strengthen their market position. Major companies in the market are investing heavily in research and development activities to introduce technologically advanced and innovative deep brain stimulation devices. They are also engaged in strategic partnerships with healthcare institutions and research organizations to enhance their product portfolios and expand their geographic reach.
Top Player’s Company Profiles
Recent Developments
In order to treat neurological and mental illnesses, Otsuka Pharmaceutical and Nexstim NBS Therapy System partnered in November 2023.
Boston Scientific Corporation announced in September 2023 that it would be purchasing some assets from Topaz Surgical, Inc. With this calculated move, Boston Scientific hopes to add Topaz's cutting-edge deep brain stimulation (DBS) device to its growing line of DBS products. The potential for improving Boston Scientific's DBS portfolio is highlighted by the expected FDA approval in 2024.
To assess the application of its RNS System for Parkinson's disease, Neuropace launched a clinical investigation in September 2023, potentially increasing the possibilities for DBS therapy.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analyses, the global deep brain stimulation devices market is experiencing significant growth and is expected to continue its upward trajectory in the coming years. The increasing prevalence of neurological disorders, such as Parkinson's disease, essential tremor, and dystonia, is one of the most significant driving factors for market expansion. Deep brain stimulation devices have emerged as an effective treatment option for these disorders, offering symptom relief, improved quality of life, and reduced medication dependence. The largest market segment in terms of product type is the non-rechargeable devices segment, driven by its cost-effectiveness and reliability. However, the fastest growing segment is the rechargeable devices segment, owing to their longer battery life and enhanced customization options. North America currently dominates the market, owing to its well-established healthcare infrastructure and high prevalence of neurological disorders. Looking ahead, the future scope of the deep brain stimulation devices market is promising, with ongoing technological advancements, increasing research and development activities, and a growing focus on personalized medicine. The market is expected to witness a surge in demand in the Asia Pacific region, driven by improving healthcare infrastructure, rising disposable incomes, and a growing awareness of deep brain stimulation therapy. Overall, the deep brain stimulation devices market is poised for remarkable growth, driven by the convergence of medical advancements, increasing disease burden, and the need for effective neurological treatments.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 1.41 billion |
Market size value in 2031 | USD 3.14 billion |
Growth Rate | 9.29% |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Deep Brain Stimulation Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Deep Brain Stimulation Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Deep Brain Stimulation Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Deep Brain Stimulation Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Deep Brain Stimulation Devices Market size was valued at USD 1.02 billion in 2021 and is poised to grow from USD 1.41 billion in 2022 to USD 2.87 billion by 2030, at a CAGR of 9.29% during the forecast period (2023-2030).
The competitive landscape of the deep brain stimulation devices market is characterized by the presence of several key players striving to gain a significant market share. These players are focused on strategies such as product development, collaborations, mergers and acquisitions, and geographic expansions to strengthen their market position. Major companies in the market are investing heavily in research and development activities to introduce technologically advanced and innovative deep brain stimulation devices. They are also engaged in strategic partnerships with healthcare institutions and research organizations to enhance their product portfolios and expand their geographic reach. 'Medtronic plc (Ireland)', 'Boston Scientific Corporation (US)', 'Abbott Laboratories (US)', 'LivaNova PLC (UK)', 'Sapiens Neuro (US)', 'Beijing PINS Medical Co., Ltd. (China)', 'SceneRay Corporation (China)', 'Nevro Corp. (US)', 'Aleva Neurotherapeutics SA (Switzerland)', 'Functional Neuromodulation Ltd. (Canada)', 'NeuroPace, Inc. (US)', 'Neuronetics, Inc. (US)', 'Brainsway Ltd. (Israel)', 'Synaptive Medical Inc. (Canada)', 'Alpha Omega Engineering Ltd. (Israel)', 'Nexeon MedSystems, Inc. (US)', 'Autonomix Medical, Inc. (US)', 'Greatbatch Medical (US)', 'SceneRay Corp. (China)', 'Saluda Medical Pty Ltd. (Australia)'
Innovations in deep brain stimulation technology have significantly improved patient outcomes, expanded the range of treatable conditions, and enhanced the overall efficacy and safety of the therapy. Technological advancements include the development of more precise targeting systems, improved stimulation parameters, and the integration of advanced features such as closed-loop systems and adaptive algorithms. These advancements enable personalized treatment approaches, better symptom management, and reduced side effects.
Increasing prevalence of neurological disorders is driving the demand: Deep brain stimulation (DBS) is a surgical procedure that uses electrical stimulation to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, and dystonia. This increase in prevalence is due to a number of factors, including the aging population, the rise in chronic diseases, and the increasing environmental toxins. The increasing prevalence of neurological disorders is driving the demand for DBS devices, as they are a highly effective treatment for many of these disorders.
The largest market region is North America. North America holds a significant share in the market due to several key factors. The region has a well-established healthcare infrastructure with advanced medical facilities and expertise in neurology. This infrastructure enables efficient diagnosis and treatment of neurological disorders, leading to a higher demand for deep brain stimulation devices. North America has a high prevalence of neurological disorders, particularly Parkinson's disease, which drives the need for effective treatment options such as deep brain stimulation. Additionally, favorable reimbursement policies and strong healthcare expenditure further support the growth of the deep brain stimulation devices market in the region.
Deep Brain Stimulation Devices Market size was valued at USD 1.02 billion in 2021 and is poised to grow from USD 1.41 billion in 2022 to USD 2.87 billion by 2030, at a CAGR of 9.29% during the forecast period (2023-2030).
The competitive landscape of the deep brain stimulation devices market is characterized by the presence of several key players striving to gain a significant market share. These players are focused on strategies such as product development, collaborations, mergers and acquisitions, and geographic expansions to strengthen their market position. Major companies in the market are investing heavily in research and development activities to introduce technologically advanced and innovative deep brain stimulation devices. They are also engaged in strategic partnerships with healthcare institutions and research organizations to enhance their product portfolios and expand their geographic reach. 'Medtronic plc (Ireland)', 'Boston Scientific Corporation (US)', 'Abbott Laboratories (US)', 'LivaNova PLC (UK)', 'Sapiens Neuro (US)', 'Beijing PINS Medical Co., Ltd. (China)', 'SceneRay Corporation (China)', 'Nevro Corp. (US)', 'Aleva Neurotherapeutics SA (Switzerland)', 'Functional Neuromodulation Ltd. (Canada)', 'NeuroPace, Inc. (US)', 'Neuronetics, Inc. (US)', 'Brainsway Ltd. (Israel)', 'Synaptive Medical Inc. (Canada)', 'Alpha Omega Engineering Ltd. (Israel)', 'Nexeon MedSystems, Inc. (US)', 'Autonomix Medical, Inc. (US)', 'Greatbatch Medical (US)', 'SceneRay Corp. (China)', 'Saluda Medical Pty Ltd. (Australia)'
Innovations in deep brain stimulation technology have significantly improved patient outcomes, expanded the range of treatable conditions, and enhanced the overall efficacy and safety of the therapy. Technological advancements include the development of more precise targeting systems, improved stimulation parameters, and the integration of advanced features such as closed-loop systems and adaptive algorithms. These advancements enable personalized treatment approaches, better symptom management, and reduced side effects.
Increasing prevalence of neurological disorders is driving the demand: Deep brain stimulation (DBS) is a surgical procedure that uses electrical stimulation to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, and dystonia. This increase in prevalence is due to a number of factors, including the aging population, the rise in chronic diseases, and the increasing environmental toxins. The increasing prevalence of neurological disorders is driving the demand for DBS devices, as they are a highly effective treatment for many of these disorders.
The largest market region is North America. North America holds a significant share in the market due to several key factors. The region has a well-established healthcare infrastructure with advanced medical facilities and expertise in neurology. This infrastructure enables efficient diagnosis and treatment of neurological disorders, leading to a higher demand for deep brain stimulation devices. North America has a high prevalence of neurological disorders, particularly Parkinson's disease, which drives the need for effective treatment options such as deep brain stimulation. Additionally, favorable reimbursement policies and strong healthcare expenditure further support the growth of the deep brain stimulation devices market in the region.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35G2217
sales@skyquestt.com
USA +1 351-333-4748